KST
← All Comparisons
blue-chip

Celltrion

068270
VS

Kia Corporation

000270

Biosimilars vs EVs - comparing global export growth stock investments

Celltrion

068270
KRX
β‚©190,000
β–² 3,000 (+1.60%)

Korea's largest biosimilar company. Global sales of blockbuster biosimilars including Remsima and Truxima.

Kia Corporation

000270
KRX
β‚©120,000
β–² 1,800 (+1.52%)

Key Hyundai Motor Group subsidiary advancing in global EV market with EV6 and EV9. Strong profitability and shareholder return policies.

Key Metrics Comparison

Celltrion
Key Metrics Comparison
Kia Corporation
β‚©190,000
Price
β‚©120,000
+1.60%
Change
+1.52%
22.7
P/E Ratio
5.9
β‚©40.8μ‘°
Market Cap
β‚©48.5μ‘°
β‚©230,000
52W High
β‚©142,000
β‚©165,000
52W Low
β‚©95,000
1.3M
Volume
2.4M

About the Companies

Celltrion

Korea's largest biosimilar company. Global sales of blockbuster biosimilars including Remsima and Truxima.

Kia Corporation

Key Hyundai Motor Group subsidiary advancing in global EV market with EV6 and EV9. Strong profitability and shareholder return policies.

β€» All data is for reference only and not real-time. Investment decisions are the sole responsibility of the investor. This comparison is not investment advice.